Bou-Jaoudeh, M., Delignat, S., Daventure, V., Astermark, J., Lévesque, H., Dimitrov, J. D., . . . Lund University, F. o. M. (2023). The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice. Haematologica, 108(5), 1322-1334. https://doi.org/10.3324/haematol.2022.281895
Chicago-referens (17:e uppl.)Bou-Jaoudeh, Melissa, et al. "The IgG-degrading Enzyme, Imlifidase, Restores the Therapeutic Activity of FVIII in Inhibitor-positive Hemophilia A Mice." Haematologica 108, no. 5 (2023): 1322-1334. https://doi.org/10.3324/haematol.2022.281895.
MLA-referens (9:e uppl.)Bou-Jaoudeh, Melissa, et al. "The IgG-degrading Enzyme, Imlifidase, Restores the Therapeutic Activity of FVIII in Inhibitor-positive Hemophilia A Mice." Haematologica, vol. 108, no. 5, 2023, pp. 1322-1334, https://doi.org/10.3324/haematol.2022.281895.
